Matches in Nanopublications for { <http://purl.org/np/RAh1j-oIkzGzdqGsjWLgBQ_nH08TK-WAaSIdOc_PmsF2s#assertion> ?p ?o ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- assertion wasAttributedTo 0000-0002-3668-2627 provenance.
- assertion generatedAtTime "2022-10-11T09:30:02.005341" provenance.
- assertion wasQuotedFrom "CAMZYOS™ is indicated for the treatment of adults with symptomatic New York Heart Association (NYHA) class II-III obstructive hypertrophic cardiomyopathy (HCM) to improve functional capacity and symptoms. CAMYOS was indicated for adults with. symptomatic. New York. Heart Association class II and III obstructive. hypertrophic. hypertrophrophyopathy." provenance.